• 4754 Citations
  • 38 h-Index
1980 …2019

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Review article
1980

Drug withdrawal syndromes. A literature review

Hodding, G. C., Jann, M. W. & Ackerman, I. P., 1 Dec 1980, In : Western Journal of Medicine. 133, 5, p. 383-391 9 p.

Research output: Contribution to journalReview article

26 Scopus citations
1984

Alternative drug therapies for mania: A literature review

Jann, M. W., Garrelts, J. C., Ereshefsky, L. & Saklad, S. R., 1 Jan 1984, In : Drug Intelligence and Clinical Pharmacy. 18, 7-8, p. 577-589 13 p.

Research output: Contribution to journalReview article

4 Scopus citations

Future of depot neuroleptic therapy: Pharmacokinetic and pharmacodynamic approaches

Ereshefsky, L., Saklad, S. R., Jann, M. W., Davis, C. M., Richards, A. & Seidel, D. R., 2 Aug 1984, In : Journal of Clinical Psychiatry. 45, 5 II, p. 50-59 10 p.

Research output: Contribution to journalReview article

62 Scopus citations
1985

Clinical Pharmacokinetics of the Depot Antipsychotics

Jann, M. W., Ereshefsky, L. & Saklad, S. R., 1 Jan 1985, In : Clinical Pharmacokinetics. 10, 4, p. 315-333 19 p.

Research output: Contribution to journalReview article

77 Scopus citations
1987

Treatment of panic and phobic disorders

Jann, M. W. & Kurtz, N. M., 1 Dec 1987, In : Clinical Pharmacy. 6, 12, p. 947-962 16 p.

Research output: Contribution to journalReview article

11 Scopus citations
1988

Buspirone: An Update on a Unique Anxiolytic Agent

Jann, M. W., 1 Jan 1988, In : Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 8, 2, p. 100-116 17 p.

Research output: Contribution to journalReview article

59 Scopus citations
1989

Pharmacokinetics of Haloperidol

Froemming, J. S., Lam, Y. W. F., Jann, M. W. & Davis, C. M., Dec 1989, In : Clinical Pharmacokinetics. 17, 6, p. 396-423 28 p.

Research output: Contribution to journalReview article

109 Scopus citations
1990

Movement disorders and new azapirone anxiolytic drugs

Jann, M. W., Froemming, J. H. & Borison, R. L., 1 Jan 1990, In : Journal of the American Board of Family Practice. 3, 2, p. 111-119 9 p.

Research output: Contribution to journalReview article

6 Scopus citations
1992

Paroxetine, sertraline, and fluvoxamine: New selective serotonin reuptake inhibitors

Grimsley, S. R. & Jann, M. W., 1 Jan 1992, In : Clinical Pharmacy. 11, 11, p. 930-957 28 p.

Research output: Contribution to journalReview article

193 Scopus citations

Therapeutic frontiers in Alzheimer's disease

Miller, S. W., Mahoney, J. M. & Jann, M. W., 30 Jun 1992, In : Pharmacotherapy. 12, 3, p. 217-231 15 p.

Research output: Contribution to journalReview article

11 Scopus citations
1993

Pharmacokinetics and Pharmacodynamics of Clozapine

Jann, M. W., Griley, S. R., Gray, E. C. & Chang, W. H., 1 Jan 1993, In : Clinical Pharmacokinetics. 24, 2, p. 161-176 16 p.

Research output: Contribution to journalReview article

203 Scopus citations
1995

Emergency Treatment of Psychotic Symptoms: Pharmacokinetic Considerations for Antipsychotic Drugs

Milton, G. V. & Jann, M. W., 1 Jan 1995, In : Clinical Pharmacokinetics. 28, 6, p. 494-504 11 p.

Research output: Contribution to journalReview article

24 Scopus citations
1997

Venlafaxine and nefazodone, two pharmacologically distinct antidepressants

Augustin, B. G., Cold, J. A. & Jann, M. W., 1 May 1997, In : Pharmacotherapy. 17, 3, p. 511-530 20 p.

Research output: Contribution to journalReview article

23 Scopus citations
1998

Drug interactions with antipsychotic agents incidence and therapeutic implications

ZumBrunnen, T. L. & Jann, M. W., 2 Jun 1998, In : CNS Drugs. 9, 5, p. 381-401 21 p.

Research output: Contribution to journalReview article

21 Scopus citations

Preclinical pharmacology of metrifonate

Jann, M. W., 1 Mar 1998, In : Pharmacotherapy. 18, 2 II SUPPL.

Research output: Contribution to journalReview article

33 Scopus citations
2000

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

VanDenBerg, C. M., Kazmi, Y. & Jann, M. W., 1 Jan 2000, In : Drugs and Aging. 16, 2, p. 123-138 16 p.

Research output: Contribution to journalReview article

29 Scopus citations

Major depression in women: a review of the literature.

Desai, H. D. & Jann, M. W., 1 Jan 2000, In : Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 40, 4, p. 525-537 13 p.

Research output: Contribution to journalReview article

68 Scopus citations

Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

Jann, M. W., 1 Jan 2000, In : Pharmacotherapy. 20, 1 I, p. 1-12 12 p.

Research output: Contribution to journalReview article

155 Scopus citations
2001

Smoking in patients receiving psychotrophic medications: A pharmacokinetic perspective

Desai, H. D., Seabolt, J. & Jann, M. W., 1 Jan 2001, In : CNS Drugs. 15, 6, p. 469-494 26 p.

Research output: Contribution to journalReview article

174 Scopus citations
2002

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

Jann, M. W., Shirley, K. L. & Small, G. W., 1 Jan 2002, In : Clinical Pharmacokinetics. 41, 10, p. 719-739 21 p.

Research output: Contribution to journalReview article

258 Scopus citations
2004

Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis

Jann, M. W., 1 Dec 2004, In : Pharmacotherapy. 24, 12 I, p. 1759-1783 25 p.

Research output: Contribution to journalReview article

38 Scopus citations
2007

Antidepressant agents for the treatment of chronic pain and depression

Jann, M. W. & Slade, J. H., 1 Nov 2007, In : Pharmacotherapy. 27, 11, p. 1571-1587 17 p.

Research output: Contribution to journalReview article

124 Scopus citations
2011

Advanced strategies for treatment of Parkinson's disease: the role of early treatment.

Jann, M. W., 1 Jan 2011, In : The American journal of managed care. 17 Suppl 12

Research output: Contribution to journalReview article

7 Scopus citations
2013

Clinically significant drug interactions with atypical antipsychotics

Kennedy, W. K., Jann, M. W. & Kutscher, E. C., 1 Dec 2013, In : CNS Drugs. 27, 12, p. 1021-1048 28 p.

Research output: Contribution to journalReview article

46 Scopus citations
2014
33 Scopus citations
2018

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.

Research output: Contribution to journalReview article

12 Scopus citations
2019

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.

Research output: Contribution to journalReview article

3 Scopus citations

The Evolving Role of Pharmacists in Transgender Health Care

Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.

Research output: Contribution to journalReview article

Open Access